Skip to main content
. 2016 Jun 14;10(2):275–282. doi: 10.1159/000446579

Fig. 5.

Fig. 5

Glut1 immunostaining of a mesenteric lymph node (a) and the lung cancer (b), counterstained with HE and presented at a magnitude of ×10 showing partial positivity with low intensity only in the lymphoid follicles (a) and positivity with high intensity in the bronchioloalveolar carcinoma of the lung (b). The protocols for Glut1 immunostaining is described by Chung et al. [9].